Dabigatran Adherence Pilot Intervention for Patients With Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Atrial Fibrillation
Interventions
BEHAVIORAL

Intervention

"1. Patient education: Patients will receive information on dabigatran, including risks, benefits and potential side effects. This information will be re-enforced during the study on a monthly basis during the IVR calls and during the pharmacy service calls to patients.~2. Tele-monitoring: We will use IVR technology to send patients an automated reminder to refill their dabigatran, rivaroxaban, and apixaban prescriptions. This call will be delivered on day 20 following each dabigatran, rivaroxaban, and apixaban prescriptions.~3. Pharmacists follow-up: If dabigatran, rivaroxaban, and apixaban have not been refilled, the pharmacy staff will contact the patient to assess reasons that the patient has not refilled the medication."

OTHER

Control

Usual care

Trial Locations (1)

80220

VA Eastern Colorado Health Care System, Denver, CO, Denver

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT01578044 - Dabigatran Adherence Pilot Intervention for Patients With Atrial Fibrillation | Biotech Hunter | Biotech Hunter